Does TEPOTINIB Cause Decreased appetite? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Decreased appetite have been filed in association with TEPOTINIB (TEPMETKO). This represents 4.1% of all adverse event reports for TEPOTINIB.
27
Reports of Decreased appetite with TEPOTINIB
4.1%
of all TEPOTINIB reports
5
Deaths
8
Hospitalizations
How Dangerous Is Decreased appetite From TEPOTINIB?
Of the 27 reports, 5 (18.5%) resulted in death, 8 (29.6%) required hospitalization.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for TEPOTINIB.
What Other Side Effects Does TEPOTINIB Cause?
Death (117)
Oedema peripheral (82)
Diarrhoea (57)
Renal impairment (57)
Oedema (56)
Fatigue (53)
Disease progression (50)
Nausea (43)
Off label use (42)
Peripheral swelling (32)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which TEPOTINIB Alternatives Have Lower Decreased appetite Risk?
TEPOTINIB vs TEPROTUMUMAB
TEPOTINIB vs TEPROTUMUMAB-TRBW
TEPOTINIB vs TERAZOSIN
TEPOTINIB vs TERAZOSIN\TERAZOSIN
TEPOTINIB vs TERBINAFINE